TY - JOUR
T1 - Is there an advantage in designing adapted, patient-specific PTV margins in intensity modulated proton beam therapy for prostate cancer?
AU - Góra, Joanna
AU - Stock, Markus
AU - Lütgendorf-Caucig, Carola
AU - Georg, Dietmar
N1 - Funding Information:
This work was supported by European Community's Seventh Framework Programme (FP7/2007/-2013) grant 215849-2 (Project PARTNER) and the Federal Ministry of Economy, Family and Youth , and the National Foundation for Research, Technology, and Development .
PY - 2013/3/1
Y1 - 2013/3/1
N2 - Purpose: To investigate robust margin strategies in intensity modulated proton therapy to account for interfractional organ motion in prostate cancer. Methods and Materials: For 9 patients, one planning computed tomography (CT) scan and daily and weekly cone beam CTs (CBCTs) were acquired and coregistered. The following planning target volume (PTV) approaches were investigated: a clinical target volume (CTV) delineated on the planning CT (CTVct) plus 10-mm margin (PTV10mm); a reduced PTV (PTVRed): CTVct plus 5 mm in the left-right (LR) and anterior-posterior (AP) directions and 8 mm in the inferior-superior (IS) directions; and a PTV Hull method: the sum of CTVct and CTVs from 5 CBCTs from the first week plus 3 mm in the LR and IS directions and 5 mm in the AP direction. For each approach, separate plans were calculated using a spot-scanning technique with 2 lateral fields. Results: Each approach achieved excellent target coverage. Differences were observed in volume receiving 98% of the prescribed dose (V98%) where PTVHull and PTV Red results were superior to the PTV10mm concept. The PTVHull approach was more robust to organ motion. The V98% for CTVs was 99.7%, whereas for PTVRed and PTV10mm plans, V98% was 98% and 96.1%, respectively. Doses to organs at risk were higher for PTVHull and PTV10mm plans than for PTV Red, but only differences between PTV10mm and PTV Red were significant. Conclusions: In terms of organ sparing, the PTV10mm method was inferior but not significantly different from the PTVRed and PTVHull approaches. PTVHull was most insensitive to target motion.
AB - Purpose: To investigate robust margin strategies in intensity modulated proton therapy to account for interfractional organ motion in prostate cancer. Methods and Materials: For 9 patients, one planning computed tomography (CT) scan and daily and weekly cone beam CTs (CBCTs) were acquired and coregistered. The following planning target volume (PTV) approaches were investigated: a clinical target volume (CTV) delineated on the planning CT (CTVct) plus 10-mm margin (PTV10mm); a reduced PTV (PTVRed): CTVct plus 5 mm in the left-right (LR) and anterior-posterior (AP) directions and 8 mm in the inferior-superior (IS) directions; and a PTV Hull method: the sum of CTVct and CTVs from 5 CBCTs from the first week plus 3 mm in the LR and IS directions and 5 mm in the AP direction. For each approach, separate plans were calculated using a spot-scanning technique with 2 lateral fields. Results: Each approach achieved excellent target coverage. Differences were observed in volume receiving 98% of the prescribed dose (V98%) where PTVHull and PTV Red results were superior to the PTV10mm concept. The PTVHull approach was more robust to organ motion. The V98% for CTVs was 99.7%, whereas for PTVRed and PTV10mm plans, V98% was 98% and 96.1%, respectively. Doses to organs at risk were higher for PTVHull and PTV10mm plans than for PTV Red, but only differences between PTV10mm and PTV Red were significant. Conclusions: In terms of organ sparing, the PTV10mm method was inferior but not significantly different from the PTVRed and PTVHull approaches. PTVHull was most insensitive to target motion.
UR - http://www.scopus.com/inward/record.url?scp=84873289366&partnerID=8YFLogxK
U2 - 10.1016/j.ijrobp.2012.05.046
DO - 10.1016/j.ijrobp.2012.05.046
M3 - Journal article
C2 - 22818417
AN - SCOPUS:84873289366
SN - 0360-3016
VL - 85
SP - 881
EP - 888
JO - International Journal of Radiation Oncology Biology Physics
JF - International Journal of Radiation Oncology Biology Physics
IS - 3
ER -